Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Peptide Inhibitor of Lymphocyte Activation Gene-3 Interaction with Fibrinogen-like Protein 1 Synergizes with Programmed Death-Ligand 1 Blockade to Restore T Cell Activity and Inhibit Tumor Growth.

Biomaterials research·2026
Same author

Mesothelin-Binding Peptide Inhibits Cell Migration and Enables Targeted Delivery of a Mitochondrial-Membrane-Damaging Peptide to Pancreatic Tumors.

Biomaterials research·2026
Same author

PD-L1/Lag3 Bispecific Immune Checkpoint Blocking Nanocage Exhibits Potent Antitumor Activity beyond Dual Blockade of PD-L1 and Lag3.

Biomaterials research·2026
Same author

Diabetes Belt has lower efficiency in providing diabetes preventive care than surrounding counties.

Health services & outcomes research methodology·2025
Same author

An enhancer-AAV toolbox to target and manipulate distinct interneuron subtypes.

Neuron·2025
Same author

Evaluation of Ceramic Membrane Filtration for Alternatives to Microplastics in Cosmetic Formulations Using FlowCam Analysis.

Membranes·2025
Same journal

The plasma membrane H<sup>+</sup>-ATPase OSA2 negatively regulates salt tolerance in rice seedlings.

Biochemical and biophysical research communications·2026
Same journal

MiR-425-5p modulation of CREB1 affects inflammatory response and motor recovery after spinal cord injury.

Biochemical and biophysical research communications·2026
Same journal

Xanthoangelol, a chalcone from Angelica keiskei, induces apoptosis in cervical cancer cell lines via the oxidative stress-mediated activation of caspase-8 and caspase-9.

Biochemical and biophysical research communications·2026
Same journal

Suchilactone ameliorates podocyte injury in membranous nephropathy by modulating the JNK/p38 MAPK pathway in vitro.

Biochemical and biophysical research communications·2026
Same journal

Palmitic acid-induced metabolic stress alters differentiation-associated gene expression in human ameloblast-like cells.

Biochemical and biophysical research communications·2026
Same journal

A transferrin receptor-based vector enables robust Type-II membrane protein display on mammalian cells.

Biochemical and biophysical research communications·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Specific gene expression patterns in liver cirrhosis.

Soyoun Kim1, Young Min Park

  • 1Department of Chemistry, Dongguk University, Seoul, Republic of Korea. skim@dongguk.edu

Biochemical and Biophysical Research Communications
|July 13, 2005
PubMed
Summary
This summary is machine-generated.

This study reveals distinct gene expression profiles in liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Researchers identified specific genes that can differentiate between active and inactive cirrhosis, aiding in early detection of HCC.

More Related Videos

Cell Type-specific Gene Expression Profiling in the Mouse Liver
10:06

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

Related Experiment Videos

Last Updated: Jun 28, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Cell Type-specific Gene Expression Profiling in the Mouse Liver
10:06

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

Area of Science:

  • Hepatology and Oncology
  • Molecular Biology
  • Genomics

Background:

  • Liver cirrhosis (LC) is a significant risk factor for hepatocellular carcinoma (HCC).
  • Understanding the genetic underpinnings of LC progression to HCC is crucial for early diagnosis and treatment.
  • Gene expression profiling offers a powerful approach to uncover molecular differences between disease states.

Purpose of the Study:

  • To investigate and characterize the distinct gene expression profiles in liver cirrhosis (LC) and hepatocellular carcinoma (HCC) tissues.
  • To identify genetic markers that can differentiate between various subtypes of LC and predict HCC development.
  • To explore molecular differences between LC without tumor association (LCT) and LC tissues near hepatic tumor tissues (near-tumor tissue, NTT).

Main Methods:

  • cDNA microarray analysis was employed to compare gene expression patterns.
  • Analysis included normal liver tissues, LC tissues (LCT), HCC tissues, and near-tumor tissues (NTT).
  • Statistical methods were used to identify differentially expressed genes and classify tissue samples.

Main Results:

  • Consistent differences in gene expression were observed among normal liver, LC, and HCC tissues.
  • LC tissues without tumor association (LCT) were distinguishable from near-tumor tissues (NTT).
  • A panel of 25 cirrhosis-specific genes differentiated NTT samples into inflammatory active (NTTa) and inactive (NTTi) groups.
  • NTTa samples exhibited gene expression patterns similar to LCT and HCC, while NTTi samples were distinct.
  • Two selected LC-specific genes effectively discriminated between different LC subtypes.

Conclusions:

  • Novel genetic subgroups within liver cirrhosis have been identified.
  • Specific gene expression patterns can distinguish active from inactive cirrhosis and predict HCC risk.
  • Candidate genes were identified for potential use as early diagnostic markers for active cirrhosis and HCC.
  • This research provides a foundation for developing targeted therapies and improved diagnostic strategies for liver diseases.